close
Add to watchlist
ATS Medical Inc (ATSI) Healthcare, Medical Equipment & Supplies
ATS Medical, Inc. engages in the development, manufacture, and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, a mechanical heart valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve; and heart valve repair products, such as ATS Simulus Flexible annuloplasty repair rings and bands, ATS Simulus Semi-Rigid Annuloplasty Ring, and ATS Simulus Adjustable repair rings. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, including the ATS CryoMaze Surgical Ablation Probe, the ATS CryoMaze and FrostByte Surgical Ablation Clamps, and the ATS CryoMaze Surgical Ablation Consoles. In addition, it is developing minimally invasive and off-pump aortic valve concepts. The company markets and sells its products through direct sales representatives and agents in the United States, France, Germany, the United Kingdom, Belgium, the Netherlands, and Switzerland; and sells through an independent distributor network to cardiac surgeons throughout the world. ATS Medical, Inc. was founded in 1987 and is based in Minneapolis, Minnesota.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 4.00 |
| Volume | 714354 |
| Volume Avg | 530349 |
| 52 Week High | 4.13 |
| 52 Week Low | 2.25 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.13 |
| EPS change Q/Q | -400% |
| EPS change Q/Q Yr ago | -61.54% |
| EPS change Q/Q next Q est | -25% |
| EPS change Y/Y | -287.5% |
| REV change Q/Q | -0.53% |
| REV change Q/Q Yr ago | 3.89% |
| EPS next Q est | -0.04 |
| EPS next Y est | -0.09 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |